Antibody Drug Conjugate

Antibody-drug conjugates or ADCs are a new class of highly potent biopharmaceutical drugs designed as a targeted therapy for the treatment of people with cancer. By combining the unique targeting capabilities of monoclonal antibodies with the cancer-killing ability of cytotoxic drugs, antibody-drug conjugates allow sensitive discrimination between healthy and diseased tissue. This means that, in contrast to traditional chemotherapeutic agents, antibody-drug conjugates target and attack the cancer cell so that healthy cells are less severely affected. The biochemical reaction between the antibody and the target protein (antigen) triggers a signal in the tumor cell, which then absorbs or internalizes the antibody together with the cytotoxin. A stable link between the antibody and cytotoxic (anti-cancer) agent is a crucial aspect of an ADC.

Linkers are based on chemical motifs including disulfides, hydrazones or peptides (cleavable), or thioethers (noncleavable) and control the distribution and delivery of the cytotoxic agent to the target cell. Cleavable and noncleavable types of linkers have been proven to be safe in preclinical and clinical trials.

    Related Conference of Antibody Drug Conjugate

    July 27-27, 2020

    Biopolymers and Bioplastics

    Paris, France
    October 12-13, 2020

    35th World Congress on Immunology

    London, UK
    October 12-13, 2020

    International Conference on Vaccine and Vaccine Research

    Manila, Philippines
    October 14-15, 2020

    13th International Conference on Allergy & Immunology

    Zurich, Switzerland
    October 15-16, 2020

    4th International Conference on Mass Spectrometry

    Cape Town, South Africa
    October 19-20, 2020

    2nd World Conference on Vaccine and Immunology

    Helsinki, Finland
    October 26-27, 2020

    13th Global Summit on Immunology and Cell Biology

    Amsterdam, Netherlands
    October 26-27, 2020

    10th International Conference on Bacteriology and Infectious Diseases

    Cape Town, South Africa
    October 28-29, 2020

    12th Annual Conference on Clinical Immunology

    Dubai, UAE
    October 29-30, 2020

    International Conference on HIV and AIDS

    Cape Town, South Africa
    November 02-03, 2020

    36th International Conference on Immunology

    Rome, Italy
    November 05-06, 2020

    4th Annual Summit on Rare Diseases and Orphan Drugs

    Paris, France
    November 18-19, 2020

    International Conference on Immunology & Immunotherapies

    Bangkok, Thailand
    December 07-08, 2020

    8th World Summit on Allergy and Clinical Immunology

    Prague, Czech Republic

    Antibody Drug Conjugate Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in